Table 5.
Correlation between S100A12 level and other acute-phase reactants in the attack-free period, acute attack period, and all patients.
Parameters | S100A12 (ng/mL) | |||||
---|---|---|---|---|---|---|
All patients(n = 57) | Attack-free periodpatients (n = 43) | Acute attackperiod (n = 14) | ||||
r | p | r | p | r | p | |
WBC count (103/mm3) | 0.195 | 0.146 | 0.044 | 0.788 | -0.037 | 0.901 |
CRP (mg/L) | 0.409 | 0.002* | 0.092 | 0.559 | 0.313 | 0.275 |
ESR (mm/h) | 0.430 | 0.001* | 0.310 | 0.043* | 0.476 | 0.085 |
SAA (mg/dL) | 0.172 | 0.200 | -0.027 | 0.866 | 0.018 | 0.951 |
Fibrinogen (mg/dL) | 0.341 | 0.009* | 0.115 | 0.463 | 0.382 | 0.177 |
Spearman correlation analysis, *p < 0.05, APR: acute phase reactants, WBC: white blood cell, CRP: C reactive protein, ESR: erythrocyte sedimentation rate, SAA: serum amyloid A.